612-345-4544 info@brightresearchpartners.com
BRIGHT Research Partners
  • HOME
  • BACKSTORY
  • OUR VALUES
  • IDEAL CLIENTS
  • THE TEAM
  • BRIGHT INSIGHTS
  • CONNECT
Select Page
Randomized Controlled Trial: The Gold Standard of Study Design

Randomized Controlled Trial: The Gold Standard of Study Design

by Scott Brown, PhD | Mar 8, 2022 | ClinReg Strategy

The randomized controlled trial (RCT) is the gold standard of clinical research, providing the highest level of scientific data for evidence-based medicine, and is often referred to as “Level I” in literature reviews and meta-analyses. RCTs are usually the most...
Five Key Qualities of Clinical Study Primary Endpoints

Five Key Qualities of Clinical Study Primary Endpoints

by Scott Brown, PhD | Sep 14, 2021 | Study Execution

Every medical device clinical study has endpoints, although they may be called something else, such as outcomes or metrics. Regardless of the name, we are talking about the objective, measurable results of a clinical study that are used to evaluate safety,...
Clinical Study Design – Begin with the End in Mind

Clinical Study Design – Begin with the End in Mind

by Scott Brown, PhD | Jul 13, 2021 | Study Execution

When designing a medical device clinical study, if you don’t begin with the end in mind, you’re likely to encounter costly surprises during the study or in the subsequent regulatory application process. With patient safety, product success, and business objectives...

Categories

  • BRIGHT Culture (4)
  • ClinReg Strategy (5)
  • Data Management (1)
  • Monitoring (2)
  • Study Execution (5)
©2021 All Rights Reserved BRIGHT Research Partners, Inc. | View our Privacy Policy | This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.